DB Fitzpatrick & Co’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,976
Closed -$1.52M 87
2024
Q3
$1.52M Sell
23,976
-111
-0.5% -$8.01K 1.33% 21
2024
Q2
$1.63M Buy
24,087
+10,324
+75% +$721K 1.51% 15
2024
Q1
$1.09M Buy
13,763
+6,659
+94% +$545K 1% 39
2023
Q4
$552K Buy
+7,104
New +$526K 0.53% 49

Other funds holding ACHC

DB Fitzpatrick & Co's ACHC Position: Q4 2024 in Review

DB Fitzpatrick & Co sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 23,976 shares — an estimated $1.52M sold.

DB Fitzpatrick & Co first reported a position in ACHC in Q4 2023 and held it in 4 quarters. The position peaked at $1.63M in Q2 2024. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • DB Fitzpatrick & Co reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • DB Fitzpatrick & Co sold 23,976 Acadia Healthcare shares in Q4 2024, an estimated $1.52M.
  • DB Fitzpatrick & Co first reported a position in Acadia Healthcare in Q4 2023 and held it in 4 quarters.
  • DB Fitzpatrick & Co's Acadia Healthcare position peaked at $1.63M in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on DB Fitzpatrick & Co's 13F filing for Q4 2024, filed 15 Jan 2025.